loading

왜 Avadel Pharmaceuticals Plc (AVDL) 주가가 하락하고 있습니까?

2025-11-26 거래 세션 동안 Avadel Pharmaceuticals Plc(AVDL) 주식이 6.67% 하락한 것을 확인했습니다. 이는 정상적인 변동성이나 다양한 내부 및 외부 요인에 의한 것일 수 있지만, 상황을 적극적으로 모니터링하고 있으며 최대한 빨리 적시에 업데이트를 제공하도록 하겠습니다!
2023-06-23:

AVDL's stock fell 11.41% following Jazz Pharmaceuticals' lawsuit against the FDA for violating the orphan drug exclusivity of Xywav by approving Avadel Pharmaceuticals' Lumryz, which is an extended-release reformulation of its high sodium oxybate product Xyrem for narcolepsy.

https://www.benzinga.com/general/biotech/23/06/32982101/jazz-pharmaceuticals-sues-fda-over-approval-of-rival-product-calls-it-unlawful

drug_manufacturers_specialty_generic RDY
$12.92
price down icon 1.30%
$24.53
price up icon 1.45%
$132.39
price down icon 0.72%
drug_manufacturers_specialty_generic RGC
$27.43
price down icon 8.75%
$12.86
price up icon 0.16%
$464.93
price down icon 1.50%
자본화:     |  볼륨(24시간):